Cardio Diagnostics Holdings, Inc. has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring its filing effective as of September 5, 2024. The filing, identified by Accession Number 0001553350-24-000071 and Submission Type POS AM, pertains to the company's registration with the SEC under File Number 333-268759. This notice of effectiveness indicates that the regulatory body has reviewed and accepted the company's submission, allowing Cardio Diagnostics Holdings to proceed with the actions outlined in their filing.

Cardio Diagnostics Holdings, Inc. has achieved a significant milestone with the United States Securities and Exchange Commission (SEC) declaring its filing effective as of September 5, 2024. The filing, identified by Accession Number 0001553350-24-000071 and Submission Type POS AM, pertains to the company's registration with the SEC under File Number 333-268759. This notice of effectiveness indicates that the regulatory body has reviewed and accepted the company's submission, allowing Cardio Diagnostics Holdings to proceed with the actions outlined in their filing.